Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Promescent Lidocaine Spray for Premature Ejaculation
NCT02241460Phase 3Unknown
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in premature ejaculation (PE) comparing Promescent Lidocaine Spray with Placebo (2 arms). Primary endpoint: Intravaginal Ejaculatory Latency Time at Week 11. Status: unknown.
02
Drugs
Promescent
03
Conditions
premature ejaculation (PE)
Beyond the preview
Go deeper on NCT02241460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241460.